361 related articles for article (PubMed ID: 30736372)
1. Podoplanin in Inflammation and Cancer.
Quintanilla M; Montero-Montero L; Renart J; Martín-Villar E
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736372
[TBL] [Abstract][Full Text] [Related]
2. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
Suzuki-Inoue K; Osada M; Ozaki Y
J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
[TBL] [Abstract][Full Text] [Related]
3. Platelet CLEC-2: Roles Beyond Hemostasis.
Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
[TBL] [Abstract][Full Text] [Related]
4. The Role of Podoplanin in Skin Diseases.
Asai J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163233
[TBL] [Abstract][Full Text] [Related]
5. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
[TBL] [Abstract][Full Text] [Related]
6. The transmembrane domain of podoplanin is required for its association with lipid rafts and the induction of epithelial-mesenchymal transition.
Fernández-Muñoz B; Yurrita MM; Martín-Villar E; Carrasco-Ramírez P; Megías D; Renart J; Quintanilla M
Int J Biochem Cell Biol; 2011 Jun; 43(6):886-96. PubMed ID: 21376833
[TBL] [Abstract][Full Text] [Related]
7. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition.
Martín-Villar E; Megías D; Castel S; Yurrita MM; Vilaró S; Quintanilla M
J Cell Sci; 2006 Nov; 119(Pt 21):4541-53. PubMed ID: 17046996
[TBL] [Abstract][Full Text] [Related]
8. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
[TBL] [Abstract][Full Text] [Related]
9. The physiological and pathophysiological roles of platelet CLEC-2.
Navarro-Núñez L; Langan SA; Nash GB; Watson SP
Thromb Haemost; 2013 Jun; 109(6):991-8. PubMed ID: 23572154
[TBL] [Abstract][Full Text] [Related]
10. New insights into the role of podoplanin in epithelial-mesenchymal transition.
Renart J; Carrasco-Ramírez P; Fernández-Muñoz B; Martín-Villar E; Montero L; Yurrita MM; Quintanilla M
Int Rev Cell Mol Biol; 2015; 317():185-239. PubMed ID: 26008786
[TBL] [Abstract][Full Text] [Related]
11. Roles of Podoplanin in Malignant Progression of Tumor.
Suzuki H; Kaneko MK; Kato Y
Cells; 2022 Feb; 11(3):. PubMed ID: 35159384
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formation.
Carrasco-Ramírez P; Greening DW; Andrés G; Gopal SK; Martín-Villar E; Renart J; Simpson RJ; Quintanilla M
Oncotarget; 2016 Mar; 7(13):16070-89. PubMed ID: 26893367
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
[TBL] [Abstract][Full Text] [Related]
14. Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction.
Tsukiji N; Inoue O; Morimoto M; Tatsumi N; Nagatomo H; Ueta K; Shirai T; Sasaki T; Otake S; Tamura S; Tachibana T; Okabe M; Hirashima M; Ozaki Y; Suzuki-Inoue K
Blood; 2018 Sep; 132(11):1167-1179. PubMed ID: 29853539
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin regulates the migration of mesenchymal stromal cells and their interaction with platelets.
Ward LSC; Sheriff L; Marshall JL; Manning JE; Brill A; Nash GB; McGettrick HM
J Cell Sci; 2019 Feb; 132(5):. PubMed ID: 30745334
[TBL] [Abstract][Full Text] [Related]
17. The Role of CLEC-2 and Its Ligands in Thromboinflammation.
Meng D; Luo M; Liu B
Front Immunol; 2021; 12():688643. PubMed ID: 34177942
[TBL] [Abstract][Full Text] [Related]
18. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
Suzuki-Inoue K
J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
[TBL] [Abstract][Full Text] [Related]
19. Podoplanin: An emerging cancer biomarker and therapeutic target.
Krishnan H; Rayes J; Miyashita T; Ishii G; Retzbach EP; Sheehan SA; Takemoto A; Chang YW; Yoneda K; Asai J; Jensen L; Chalise L; Natsume A; Goldberg GS
Cancer Sci; 2018 May; 109(5):1292-1299. PubMed ID: 29575529
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin: Its roles and functions in neurological diseases and brain cancers.
Wang Y; Peng D; Huang Y; Cao Y; Li H; Zhang X
Front Pharmacol; 2022; 13():964973. PubMed ID: 36176432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
